Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Tscan Therapeutics Inc’s stock clocked out at $1.54, down -8.33% from its previous closing price of $1.68. In other words, the price has decreased by -$8.33 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
To gain a deeper understanding of TCRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.55 and its Current Ratio is at 8.55. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on May 16, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On May 13, 2024, Needham started tracking the stock assigning a Buy rating and target price of $11.
On June 22, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $8.Wedbush initiated its Outperform rating on June 22, 2023, with a $8 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 19 ’25 when Lynx1 Capital Management LP bought 1,388,794 shares for $1.20 per share. The transaction valued at 1,666,553 led to the insider holds 6,746,141 shares of the business.
Lynx1 Capital Management LP bought 1,200,000 shares of TCRX for $1,440,000 on May 20 ’25. The 10% Owner now owns 7,946,141 shares after completing the transaction at $1.20 per share. On Dec 13 ’24, another insider, Lynx1 Capital Management LP, who serves as the 10% Owner of the company, bought 100,000 shares for $2.90 each. As a result, the insider paid 290,140 and bolstered with 5,357,347 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 19.72 while its Price-to-Book (P/B) ratio in mrq is 0.41.
Stock Price History:
Over the past 52 weeks, TCRX has reached a high of $7.89, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is 3.53%, while the 200-Day Moving Average is calculated to be -48.46%.
Shares Statistics:
A total of 52.31M shares are outstanding, with a floating share count of 43.83M. Insiders hold about 22.56% of the company’s shares, while institutions hold 71.46% stake in the company.
